Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Verrica Pharmaceuticals Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +16 vs. Q3 2025
- Shares held
- 5.20M
- +2.73M (+110.4%) vs. Q3 2025
- Total value
- $43.2M
- +$32.6M (+307.8%) vs. Q3 2025
- New holders
- 22
- 5 more added
- Sold out
- 6
- 10 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $28.5M |
| Q1 2026 | 39 | $25.3M |
| Q4 2025 | 50 | $43.2M |
| Q3 2025 | 34 | $10.6M |
| Q2 2025 | 59 | $13.4M |
| Q1 2025 | 75 | $13.0M |
| Q4 2024 | 81 | $21.0M |
| Q3 2024 | 79 | $21.6M |
| Q2 2024 | 74 | $135.9M |
| Q1 2024 | 62 | $105.1M |
| Q4 2023 | 64 | $131.8M |
| Q3 2023 | 67 | $58.5M |
| Q2 2023 | 63 | $84.2M |
| Q1 2023 | 60 | $84.2M |
| Q4 2022 | 50 | $29.8M |
| Q3 2022 | 49 | $29.9M |
| Q2 2022 | 57 | $21.8M |
| Q1 2022 | 51 | $72.1M |
| Q4 2021 | 45 | $82.0M |
| Q3 2021 | 49 | $114.6M |
| Q2 2021 | 53 | $112.3M |
| Q1 2021 | 51 | $150.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Verrica Pharmaceuticals Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Covestor Ltd | 54 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $8 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 2 | $17 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3 | $25 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 24 | $199 | 0.00% | −41,608−99.9% | Reduced |
| Optiver Holding B.V. | 31 | $258 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 47 | $391 | 0.00% | +47 | New |
| The PNC Financial Services Group, Inc. | 102 | $847 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 110 | $914 | 0.00% | −14−11.3% | Reduced |
| International Assets Investment Management, LLC | 175 | $1.45K | 0.00% | +175 | New |
| New England Capital Financial Advisors LLC | 200 | $1.66K | 0.00% | 00.0% | Unchanged |
| Salomon & Ludwin, LLC | 290 | $2.57K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 416 | $3.00K | 0.00% | −793−65.6% | Reduced |
| Fortitude Family Office, LLC | 608 | $5.05K | 0.00% | +608 | New |
| Capital Analysts, LLC | 1,500 | $12.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,342 | $27.8K | 0.00% | +1,799+116.6% | Added |
| Bank of America Corp | 4,343 | $36.1K | 0.00% | +4,271+5,931.9% | Added |
| BlackRock, Inc. | 5,685 | $47.2K | 0.00% | −463−7.5% | Reduced |
| Man Group plc | 11,287 | $93.8K | 0.00% | +11,287 | New |
| Quadrature Capital Ltd | 11,954 | $99.3K | 0.00% | +11,954 | New |
| Bridgeway Capital Management, LLC | 12,000 | $99.7K | 0.00% | 00.0% | Unchanged |
| Beck Mack & Oliver LLC | 12,000 | $99.7K | 0.00% | +12,000 | New |
| XTX Topco Ltd | 14,662 | $121.8K | 0.00% | +14,662 | New |
| Walleye Capital LLC | 15,240 | $126.6K | 0.00% | +15,240 | New |
| Legacy Trust | 17,234 | $143.2K | 0.03% | +17,234 | New |
| HRT Financial LP | 17,356 | $144.0K | 0.00% | +17,356 | New |
| Goldman Sachs Group Inc | 18,621 | $154.7K | 0.00% | +18,621 | New |
| Northern Trust Corp | 20,024 | $166.4K | 0.00% | −70.0% | Reduced |
| Morgan Stanley | 22,009 | $182.9K | 0.00% | +321+1.5% | Added |
| Omers Administration Corp | 22,600 | $187.8K | 0.00% | +22,600 | New |
| Millennium Management LLC | 23,123 | $192.2K | 0.00% | −48,867−67.9% | Reduced |
| State Street Corp | 23,481 | $195.1K | 0.00% | +2,900+14.1% | Added |
| Mariner, LLC | 24,544 | $204.0K | 0.00% | −60.0% | Reduced |
| Renaissance Technologies LLC | 26,400 | $219.4K | 0.00% | −2,791−9.6% | Reduced |
| Sovran Advisors, LLC | 32,658 | $248.5K | 0.02% | −41,147−55.8% | Reduced |
| Squarepoint Ops LLC | 33,270 | $276.5K | 0.00% | +33,270 | New |
| Two Sigma Advisers, LP | 44,430 | $369.2K | 0.00% | +44,430 | New |
| Geode Capital Management, LLC | 67,659 | $562.4K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 85,173 | $707.8K | 0.00% | +85,173 | New |
| Jane Street Group, LLC | 101,722 | $845.3K | 0.00% | +101,722 | New |
| Two Sigma Investments, LP | 118,218 | $982.4K | 0.00% | +118,218 | New |
| Vanguard Group Inc | 138,194 | $1.15M | 0.00% | −87,016−38.6% | Reduced |
| DAFNA Capital Management LLC | 173,451 | $1.44M | 0.33% | +173,451 | New |
| Kalehua Capital Management LLC | 235,779 | $1.96M | 1.94% | +235,779 | New |
| Boothbay Fund Management, LLC | 280,734 | $2.33M | 0.06% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 353,669 | $2.94M | 2.32% | +353,669 | New |
| Velan Capital Investment Management LP | 471,559 | $3.92M | 2.28% | +471,559 | New |
| Affinity Asset Advisors, LLC | 707,338 | $5.88M | 0.42% | +707,338 | New |
| Caligan Partners LP | 923,910 | $7.68M | 0.70% | 00.0% | Unchanged |
| Armistice Capital, LLC | 1,118,925 | $9.30M | 0.23% | +479,732+75.1% | Added |
| FMR LLC | 0 | $0 | 0.00% | −3,337−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2,065−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −568−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |